Recommendations for the Nonclinical Development of Topical Microbicides for Prevention of HIV Transmission: An Update
- 1 May 2004
- journal article
- review article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 36 (1) , 541-552
- https://doi.org/10.1097/00126334-200405010-00001
Abstract
The development of methods to prevent HIV infection is critical to curbing the rising epidemic. Topical microbicides represent a potential new strategy for reduction of HIV transmission. The purpose of this article is to update and expand upon the nonclinical recommendations of a previously published document on the development of microbicides prepared by the International Working Group on Microbicides. The nonclinical studies discussed here represent general concepts and regulatory considerations that are pertinent to the development of topical microbicides for prevention or reduction of HIV transmission. Essential early steps in product development include the determination of antiviral activity, cytotoxicity, mechanism of action, pathways to resistance, and cross-resistance to approved drugs. Other parameters to consider include activity against vaginal microflora and pathogens that cause sexually transmitted diseases. Before and during clinical trials, nonclinical data on toxicology and pharmacokinetics should be obtained. Finally, product quality issues, including microbicide formulation characteristics, interaction with other products, and stability, should be addressed.Keywords
This publication has 59 references indexed in Scilit:
- Microbicides: a new approach to preventing HIV and other sexually transmitted infectionsNature Reviews Drug Discovery, 2002
- Human monoclonal antibody stability and activity at vaginal pHJournal of Reproductive Immunology, 2002
- Scientific considerations for the regulation and clinical evaluation of HIV/AIDS preventive vaccinesAIDS, 2002
- Diffusion of Macromolecules and Virus-Like Particles in Human Cervical MucusBiophysical Journal, 2001
- The Global HIV and AIDS Epidemic, 2001Published by American Medical Association (AMA) ,2001
- Recommendations for the clinical development of topical microbicides: an updateAIDS, 2001
- Comparison of Microbicides for Efficacy in Protecting Mice Against Vaginal Challenge With Herpes Simplex Virus Type 2, Cytotoxicity, Antibacterial Properties, and Sperm ImmobilizationSexually Transmitted Diseases, 2001
- T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmissionAIDS, 2001
- Preclinical studies on thiocarboxanilide UC-781 as a virucidal agentAIDS, 1998
- Discovery and in Vitro Development of AIDS Antiviral Drugs as BiopharmaceuticalsPublished by Elsevier ,1995